Serotonin controlling feeding and satiety

[1]  J. Homberg,et al.  The neurodevelopmental effects of serotonin: A behavioural perspective , 2015, Behavioural Brain Research.

[2]  N. Alenina,et al.  Life without brain serotonin: Reevaluation of serotonin function with mice deficient in brain serotonin synthesis , 2015, Behavioural Brain Research.

[3]  S. Langley-Evans,et al.  Nutrition in early life and the programming of adult disease: a review. , 2015, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[4]  A. Garfield,et al.  Distribution of cells responsive to 5-HT6 receptor antagonist-induced hypophagia , 2014, Behavioural Brain Research.

[5]  G. Bray,et al.  Update on obesity pharmacotherapy , 2014, Annals of the New York Academy of Sciences.

[6]  F. Wright,et al.  Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption , 2014, Psychopharmacology.

[7]  S. E. Gartside,et al.  The role of serotonin in feeding and gut contractions in the honeybee☆ , 2014, Journal of insect physiology.

[8]  A. Zarate,et al.  Role of prenatal undernutrition in the expression of serotonin, dopamine and leptin receptors in adult mice: Implications of food intake , 2013, Molecular medicine reports.

[9]  N. Rowland,et al.  Obituary , 2001, Psychopharmacology.

[10]  S. Yanovski,et al.  Long-term drug treatment for obesity: a systematic and clinical review. , 2014, JAMA.

[11]  F. Wright,et al.  On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination , 2014, Psychopharmacology.

[12]  S. Higgs,et al.  Effects of the 5-HT2C receptor agonist meta-chlorophenylpiperazine on appetite, food intake and emotional processing in healthy volunteers , 2014, Psychopharmacology.

[13]  R. Palmiter,et al.  Genetic identification of a neural circuit that suppresses appetite , 2013, Nature.

[14]  P. Fletcher,et al.  From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists. , 2013, Trends in pharmacological sciences.

[15]  T. Dinan,et al.  Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward , 2013, Front. Neurosci..

[16]  L. Tecott,et al.  Serotonin and the regulation of mammalian energy balance , 2013, Front. Neurosci..

[17]  A. Kalsbeek,et al.  Melanocortin 4 receptor distribution in the human hypothalamus. , 2013, European journal of endocrinology.

[18]  R. Adan.  Mechanisms underlying current and future anti-obesity drugs , 2013, Trends in Neurosciences.

[19]  Alexander W. Johnson.  Eating beyond metabolic need: how environmental cues influence feeding behavior , 2013, Trends in Neurosciences.

[20]  C. Marsden,et al.  How do we re-engage the pharmaceutical industry in research on serotonin and psychiatric disorders? , 2013, ACS chemical neuroscience.

[21]  P. Gaspar,et al.  Postnatal growth defects in mice with constitutive depletion of central serotonin. , 2013, ACS chemical neuroscience.

[22]  N. Decher,et al.  Putative Impact of RNA Editing on Drug Discovery , 2013, Chemical biology & drug design.

[23]  J. Gosden,et al.  A review of late-stage CNS drug candidates for the treatment of obesity , 2013, International Journal of Obesity.

[24]  T. Dinan,et al.  Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) Attenuates Ghrelin-mediated Signaling* , 2012, The Journal of Biological Chemistry.

[25]  H. Grill,et al.  Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. , 2012, Cell metabolism.

[26]  M. Tschöp,et al.  Anti-obesity drugs: past, present and future , 2012, Disease Models & Mechanisms.

[27]  T. Oberlander.  Fetal serotonin signaling: setting pathways for early childhood development and behavior. , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[28]  H. Berthoud.  The neurobiology of food intake in an obesogenic environment , 2012, Proceedings of the Nutrition Society.

[29]  William F. C. Baaré,et al.  Obesity is associated with high serotonin 4 receptor availability in the brain reward circuitry , 2012, NeuroImage.

[30]  J. Betley,et al.  Deconstruction of a neural circuit for hunger , 2012, Nature.

[31]  P. Fletcher,et al.  The 5-HT2C Receptor Agonist Lorcaserin Reduces Nicotine Self-Administration, Discrimination, and Reinstatement: Relationship to Feeding Behavior and Impulse Control , 2012, Neuropsychopharmacology.

[32]  R. Palmiter,et al.  Deciphering a neuronal circuit that mediates appetite , 2012, Nature.

[33]  T. Dinan,et al.  Dynamic 5-HT2C Receptor Editing in a Mouse Model of Obesity , 2012, PloS one.

[34]  J. Sze,et al.  Reduced Serotonin Reuptake Transporter (SERT) Function Causes Insulin Resistance and Hepatic Steatosis Independent of Food Intake , 2012, PloS one.

[35]  Jong-Woo Sohn,et al.  Functional Heterogeneity of Arcuate Nucleus Pro-Opiomelanocortin Neurons: Implications for Diverging Melanocortin Pathways , 2012, Molecular Neurobiology.

[36]  H. Berthoud.  Metabolic and hedonic drives in the neural control of appetite: who is the boss? , 2011, Current Opinion in Neurobiology.

[37]  J. Vowinckel,et al.  Novel roles for biogenic monoamines: from monoamines in transglutaminase‐mediated post‐translational protein modification to monoaminylation deregulation diseases , 2011, The FEBS journal.

[38]  K. Fone,et al.  Exposure to maternal consumption of cafeteria diet during the lactation period programmes feeding behaviour in the rat , 2011, International Journal of Developmental Neuroscience.

[39]  P. Levitt,et al.  Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain , 2011, Neuroscience.

[40]  J. Elmquist,et al.  Serotonin 2C Receptor Activates a Distinct Population of Arcuate Pro-opiomelanocortin Neurons via TRPC Channels , 2011, Neuron.

[41]  K. Nonogaki,et al.  The contribution of serotonin 5-HT2C and melanocortin-4 receptors to the satiety signaling of glucagon-like peptide 1 and liraglutide, a glucagon-like peptide 1 receptor agonist, in mice. , 2011, Biochemical and biophysical research communications.

[42]  G. Dawson,et al.  Validation of experimental medicine methods in psychiatry: the P1vital approach and experience. , 2011, Biochemical pharmacology.

[43]  S. Ozanne,et al.  Developmental Programming in Response to Maternal Overnutrition , 2011, Front. Gene..

[44]  J. Dalley,et al.  Leptin does not directly affect CNS serotonin neurons to influence appetite. , 2011, Cell metabolism.

[45]  H. Inskip,et al.  The long-term effects of prenatal development on growth and metabolism. , 2011, Seminars in reproductive medicine.

[46]  A. Greenshaw,et al.  5-HT receptors and reward-related behaviour: A review , 2011, Neuroscience & Biobehavioral Reviews.

[47]  Nu-Chu Liang,et al.  The use of serotonergic drugs to treat obesity – is there any hope? , 2011, Drug design, development and therapy.

[48]  J. Bockaert,et al.  5-HT(4) receptors, a place in the sun: act two. , 2011, Current opinion in pharmacology.

[49]  Kenji F. Tanaka,et al.  Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications , 2011, The Journal of experimental medicine.

[50]  K. Lesch,et al.  Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice , 2011, European Neuropsychopharmacology.

[51]  A. Cooper,et al.  Reversal of sibutramine-induced anorexia with a selective 5-HT2C receptor antagonist , 2011, Psychopharmacology.

[52]  J. Halford.  Obesity: Lorcaserin—not a new weapon in the battle with appetite , 2010, Nature Reviews Endocrinology.

[53]  Z. Halpern,et al.  Development and Characterization of High Affinity Leptins and Leptin Antagonists* , 2010, The Journal of Biological Chemistry.

[54]  P. Currie,et al.  Hypothalamic paraventricular 5-hydroxytryptamine inhibits the effects of ghrelin on eating and energy substrate utilization , 2010, Pharmacology Biochemistry and Behavior.

[55]  N. Rowland,et al.  Effect of serotonergic anorectics on food intake and induction of Fos in brain of mice with disruption of melanocortin 3 and/or 4 receptors , 2010, Pharmacology Biochemistry and Behavior.

[56]  R. Rodgers,et al.  Behavioural satiety sequence (BSS): Separating wheat from chaff in the behavioural pharmacology of appetite , 2010, Pharmacology Biochemistry and Behavior.

[57]  T. Kaji,et al.  Hypothalamic orexin and pro-opiomelanocortin activities are essential for the anorexic effects of m-chlorophenylpiperazine in mice. , 2010, The international journal of neuropsychopharmacology.

[58]  T. Cremers,et al.  Therapeutic Potential of 5-HT2C Receptor Ligands , 2010, TheScientificWorldJournal.

[59]  L. Garcia-Segura,et al.  Leptin accumulation in hypothalamic and dorsal raphe neurons is inversely correlated with brain serotonin content , 2010, Brain Research.

[60]  S. Bouret.  Role of early hormonal and nutritional experiences in shaping feeding behavior and hypothalamic development. , 2010, The Journal of nutrition.

[61]  P. Bertrand,et al.  Serotonin release and uptake in the gastrointestinal tract , 2010, Autonomic Neuroscience.

[62]  J. Blundell,et al.  Sibutramine & naloxone: Infra-additive interaction in the regulation of appetite? , 2010, Behavioural Brain Research.

[63]  A. Oswal,et al.  Leptin and the Control of Body Weight: A Review of Its Diverse Central Targets, Signaling Mechanisms, and Role in the Pathogenesis of Obesity , 2010, Obesity.

[64]  K. Lesch,et al.  Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity , 2010, International Journal of Obesity.

[65]  E. Azmitia.  Evolution of serotonin: sunlight to suicide , 2010 .

[66]  J. Hornung.  CHAPTER 1.3 - The Neuronatomy of the Serotonergic System , 2010 .

[67]  Michael Bader,et al.  Intracellular Serotonin Modulates Insulin Secretion from Pancreatic β-Cells by Protein Serotonylation , 2009, PLoS biology.

[68]  Kenji F. Tanaka,et al.  A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure , 2009, Cell.

[69]  P. Fletcher,et al.  Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout mice , 2009, Neuropharmacology.

[70]  S. Langley-Evans,et al.  Nutritional programming of disease: unravelling the mechanism , 2009, Journal of anatomy.

[71]  R. Plehm,et al.  Growth retardation and altered autonomic control in mice lacking brain serotonin , 2009, Proceedings of the National Academy of Sciences.

[72]  P. Taylor,et al.  Maternal Obesity Induced by Diet in Rats Permanently Influences Central Processes Regulating Food Intake in Offspring , 2009, PloS one.

[73]  R. Rothman,et al.  Serotonergic drugs and valvular heart disease , 2009, Expert opinion on drug safety.

[74]  C. Anderson,et al.  Lorcaserin (APD356), a Selective 5‐HT2C Agonist, Reduces Body Weight in Obese Men and Women , 2009, Obesity.

[75]  M. Camilleri.  Serotonin in the gastrointestinal tract , 2009, Current opinion in endocrinology, diabetes, and obesity.

[76]  P. Y. Xiu,et al.  Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia , 2009, Behavioural Brain Research.

[77]  A. Garfield,et al.  Pharmacological targeting of the serotonergic system for the treatment of obesity , 2009, The Journal of physiology.

[78]  L. Asarian.  Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[79]  N. Kassis,et al.  A Dietary Fat Excess Alters Metabolic and Neuroendocrine Responses Before the Onset of Metabolic Diseases , 2009, Cellular and Molecular Neurobiology.

[80]  Kevin W. Williams,et al.  5-HT2CRs Expressed by Pro-Opiomelanocortin Neurons Regulate Energy Homeostasis , 2008, Neuron.

[81]  J. Metzger,et al.  Reduced sensitivity to diet-induced obesity in mice carrying a mutant 5-HT6 receptor , 2008, Brain Research.

[82]  T. Lanthorn,et al.  Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants , 2008, PloS one.

[83]  L. Oyama,et al.  Impairment of the serotonergic control of feeding in adult female rats exposed to intra-uterine malnutrition , 2008, British Journal of Nutrition.

[84]  G. Sanger.  5-hydroxytryptamine and the gastrointestinal tract: where next? , 2008, Trends in pharmacological sciences.

[85]  M. Vacca,et al.  Glucagon-like peptide 1 (7–36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus , 2008, Peptides.

[86]  T. Sharp,et al.  Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine , 2008, Psychopharmacology.

[87]  Brian M. Smith,et al.  Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization , 2008, Journal of Pharmacology and Experimental Therapeutics.

[88]  R. Tallarida,et al.  Effects of a Cannabinoid1 Receptor Antagonist and Serotonin2C Receptor Agonist Alone and in Combination on Motivation for Palatable Food: A Dose-Addition Analysis Study in Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.

[89]  I. Lucki,et al.  Sucrose intake and fasting glucose levels in 5-HT1A and 5-HT1B receptor mutant mice , 2008, Physiology & Behavior.

[90]  S. O’Rahilly,et al.  Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. , 2008, Endocrinology.

[91]  R. Orozco-Solis,et al.  Perinatal protein restriction reduces the inhibitory action of serotonin on food intake , 2008, The European journal of neuroscience.

[92]  X. Codony,et al.  Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders. , 2008, Pharmacology & therapeutics.

[93]  F. Cavagnini,et al.  Neuroendocrine control of food intake. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[94]  南部 忠洋.  Distribution of orexin neurons in the adult rat brain , 2007 .

[95]  T. Sharp,et al.  Important messages in the 'post': recent discoveries in 5-HT neurone feedback control. , 2007, Trends in pharmacological sciences.

[96]  J. Elmquist,et al.  Serotonin 2C Receptor Agonists Improve Type 2 Diabetes via Melanocortin-4 Receptor Signaling Pathways , 2007, Cell metabolism.

[97]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[98]  D. Figlewicz,et al.  Modulation of food reward by adiposity signals , 2007, Physiology & Behavior.

[99]  G. Kennett,et al.  5‐HT2C receptor activation inhibits appetitive and consummatory components of feeding and increases brain c‐fos immunoreactivity in mice , 2007, The European journal of neuroscience.

[100]  J. M. Mancilla-Díaz,et al.  The effects of 5-HT1A and 5-HT2C receptor agonists on behavioral satiety sequence in rats , 2007, Neuroscience Letters.

[101]  M. R. Hayes,et al.  Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[102]  L. B. Knudsen,et al.  Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not , 2007, Diabetes.

[103]  J. Tack,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders , 2007 .

[104]  Biao Wang,et al.  Deletion of the serotonin 2c receptor from transgenic mice overexpressing leptin does not affect their lipodystrophy but exacerbates their diet-induced obesity. , 2006, Biochemical and biophysical research communications.

[105]  H. Berthoud,et al.  Brainstem mechanisms integrating gut-derived satiety signals and descending forebrain information in the control of meal size , 2006, Physiology & Behavior.

[106]  C. Müller,et al.  Intracellular 5-HT 2C-receptor dephosphorylation: a new target for treating drug addiction. , 2006, Trends in pharmacological sciences.

[107]  Sanbing Shen,et al.  Increased Expression of the 5-HT Transporter Confers a Low- Anxiety Phenotype Linked to Decreased 5-HT Transmission , 2006, The Journal of Neuroscience.

[108]  M. R. Hayes,et al.  Dorsal hindbrain 5-HT3 receptors participate in control of meal size and mediate CCK-induced satiation , 2006, Brain Research.

[109]  J. Holenz,et al.  Chronic 5‐HT6 receptor modulation by E‐6837 induces hypophagia and sustained weight loss in diet‐induced obese rats , 2006, British journal of pharmacology.

[110]  B. Levin.  Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[111]  R. Gillette.  Evolution and function in serotonergic systems. , 2006, Integrative and comparative biology.

[112]  Olivier Boss,et al.  Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake , 2006, Neuron.

[113]  S. Aja.  Serotonin-3 receptors in gastric mechanisms of cholecystokinin-induced satiety. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[114]  M. R. Hayes,et al.  Gastric distension enhances CCK-induced Fos-like immunoreactivity in the dorsal hindbrain by activating 5-HT3 receptors , 2006, Brain Research.

[115]  J. Fernstrom,et al.  Effects of chronic fenfluramine administration on hypothalamic neuropeptide mRNA expression , 2006, Brain Research.

[116]  Y. Sugimoto,et al.  Involvement of leptin in hypophagia induced by the serotonin precursor 5-hydroxytryptophan (5-HTP) in mice. , 2006, Biological & pharmaceutical bulletin.

[117]  S. Bloom,et al.  The regulation of appetite , 2005, Archives of Disease in Childhood.

[118]  G. Kennett,et al.  Evidence that hypophagia induced bymCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors , 2006, Psychopharmacology.

[119]  G. Kennett,et al.  Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse , 2006, Psychopharmacology.

[120]  Robert A. McGovern,et al.  Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure , 2005, Cell.

[121]  M. R. Hayes,et al.  CCK and 5-HT act synergistically to suppress food intake through simultaneous activation of CCK-1 and 5-HT3 receptors , 2005, Peptides.

[122]  M. Tonini,et al.  5‐Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[123]  Stephen R. Bloom,et al.  The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal–brainstem–hypothalamic pathway , 2005, Brain Research.

[124]  K. Toshinai,et al.  Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus , 2005, Regulatory Peptides.

[125]  C. Dourish,et al.  Behavioural evidence thatd-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype , 1996, Psychopharmacology.

[126]  D. Coleman.  Effects of parabiosis of obese with diabetes and normal mice , 1973, Diabetologia.

[127]  P. Willner,et al.  Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence , 2005, Psychopharmacology.

[128]  C. Dourish,et al.  An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats , 2005, Psychopharmacology.

[129]  K. Simpson,et al.  Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers , 2005, Psychopharmacology.

[130]  A. Andrews,et al.  Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression , 2004, Journal of Neuroscience Methods.

[131]  Samit Shah,et al.  5-HT3 receptors participate in CCK-induced suppression of food intake by delaying gastric emptying. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[132]  M. R. Hayes,et al.  Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors , 2004, Physiology & Behavior.

[133]  J. Halford.  Clinical pharmacotherapy for obesity: current drugs and those in advanced development. , 2004, Current drug targets.

[134]  A. Rex,et al.  Effect of 5-HT1A receptor activation on hypothalamic glucose. , 2004, Pharmacological research.

[135]  M. Fujimiya,et al.  Gastric distension-induced release of 5-HT stimulates c-fos expression in specific brain nuclei via 5-HT3 receptors in conscious rats. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[136]  G. Kennett,et al.  Tonic regulation of satiety by 5‐HT1B receptors in the mouse: converging evidence from behavioural and c‐fos immunoreactivity studies? , 2004, The European journal of neuroscience.

[137]  G. Kennett,et al.  Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice , 2004, Psychopharmacology.

[138]  G. Fink,et al.  The Fenfluramine Metabolite (+)-Norfenfluramine Is Vasoactive , 2004, Journal of Pharmacology and Experimental Therapeutics.

[139]  S. Morrison.  Activation of 5-HT1A receptors in raphe pallidus inhibits leptin-evoked increases in brown adipose tissue thermogenesis. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[140]  R. Ritter,et al.  Gastrointestinal mechanisms of satiation for food , 2004, Physiology & Behavior.

[141]  J. Halford,et al.  The pharmacology of human appetite expression. , 2004, Current drug targets.

[142]  S. Bouret,et al.  Formation of Projection Pathways from the Arcuate Nucleus of the Hypothalamus to Hypothalamic Regions Implicated in the Neural Control of Feeding Behavior in Mice , 2004, The Journal of Neuroscience.

[143]  C. Marsden,et al.  5-ht6 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[144]  L. Lanfumey,et al.  5-HT1 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[145]  B. Costall,et al.  5-HT3 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[146]  C. Marsden,et al.  Evidence for the involvement of the 5-HT1A receptor in CCK induced satiety in rats , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[147]  S. Garattini,et al.  Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

[148]  P. Willner,et al.  Fenfluramine disrupts the behavioural satiety sequence in rats , 2004, Psychopharmacology.

[149]  S. Cooper,et al.  Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors , 2004, Psychopharmacology.

[150]  P. G. Clifton,et al.  A behavioural profile of fluoxetine-induced anorexia , 2004, Psychopharmacology.

[151]  P. Hutson,et al.  Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia , 2004, Psychopharmacology.

[152]  S. Iversen,et al.  8-OH-DPAT elicits feeding and not chewing: evidence from liquid diet studies and a diet choice test , 2004, Psychopharmacology.

[153]  C. Dourish,et al.  Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat , 2004, Psychopharmacology.

[154]  P. Fletcher,et al.  Dissociation of the anorectic actions of 5-HTP and fenfluramine , 2004, Psychopharmacology.

[155]  R. Norgren,et al.  Oral sucrose stimulation increases accumbens dopamine in the rat. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[156]  G. W. Price,et al.  Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. , 2003, Molecular pharmacology.

[157]  M. Bader,et al.  A unique central tryptophan hydroxylase isoform. , 2003, Biochemical pharmacology.

[158]  J. Blundell,et al.  Palatability, food intake and the behavioural satiety sequence in male rats , 2003, Physiology & Behavior.

[159]  Y. Sugimoto,et al.  Role of serotonergic mechanisms in leptin-induced suppression of milk intake in mice , 2003, Neuroscience Letters.

[160]  J. Horowitz,et al.  Serotonergic dorsal raphe neurons from obese zucker rats are hyperexcitable , 2003, Neuroscience.

[161]  E. Ribeiro,et al.  Effect of leptin on the acute feeding-induced hypothalamic serotonergic stimulation in normal rats , 2003, Regulatory Peptides.

[162]  M. Low,et al.  Central Serotonin and Melanocortin Pathways Regulating Energy Homeostasis , 2003, Annals of the New York Academy of Sciences.

[163]  T. Sharp,et al.  Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate–early gene Arc in rat brain , 2003, Neuropharmacology.

[164]  D. Cocchi,et al.  Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting , 2003, Regulatory Peptides.

[165]  C. Saper,et al.  Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat , 2003, The Journal of comparative neurology.

[166]  Michael Esterman,et al.  The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis , 2003, Neuron.

[167]  B. Hoebel,et al.  Cholecystokinin combined with serotonin in the hypothalamus limits accumbens dopamine release while increasing acetylcholine: a possible satiation mechanism , 2003, Brain Research.

[168]  W. Langhans,et al.  Evidence that the anorexia induced by lipopolysaccharide is mediated by the 5-HT2C receptor , 2003, Pharmacology Biochemistry and Behavior.

[169]  H. Haas,et al.  Convergent Excitation of Dorsal Raphe Serotonin Neurons by Multiple Arousal Systems (Orexin/Hypocretin, Histamine and Noradrenaline) , 2002, The Journal of Neuroscience.

[170]  C. Saper,et al.  The Need to Feed Homeostatic and Hedonic Control of Eating , 2002, Neuron.

[171]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[172]  M. Low,et al.  Activation of Central Melanocortin Pathways by Fenfluramine , 2002, Science.

[173]  L. Tecott,et al.  Altered gene expressions involved in energy expenditure in 5-HT(2C) receptor mutant mice. , 2002, Biochemical and biophysical research communications.

[174]  C. Sternini,et al.  Expression of 5-HT3 receptors in the rat gastrointestinal tract. , 2002, Gastroenterology.

[175]  H. Berthoud,et al.  Multiple neural systems controlling food intake and body weight , 2002, Neuroscience & Biobehavioral Reviews.

[176]  T. Horvath,et al.  Leptin Uptake by Serotonergic Neurones of the Dorsal Raphe , 2002, Journal of neuroendocrinology.

[177]  M. Collin,et al.  5‐HT1A receptor immunoreactivity in hypothalamic neurons involved in body weight control , 2002, Neuroreport.

[178]  H. Fink,et al.  Role of 5-HT1A receptors in the control of food intake in obese Zucker rats of different ages , 2002, Pharmacology Biochemistry and Behavior.

[179]  A. Lira,et al.  Hypothalamic paraventricular 5-hydroxytryptamine: Receptor-specific inhibition of NPY-stimulated eating and energy metabolism , 2002, Pharmacology Biochemistry and Behavior.

[180]  C. Dourish,et al.  Serotonin 2C receptor agonists and the behavioural satiety sequence in mice , 2002, Pharmacology Biochemistry and Behavior.

[181]  Daniel Hoyer,et al.  Molecular, pharmacological and functional diversity of 5-HT receptors , 2002, Pharmacology Biochemistry and Behavior.

[182]  K. Simansky,et al.  Parabrachial infusion of d-fenfluramine reduces food intake Blockade by the 5-HT1B antagonist SB-216641 , 2002, Pharmacology Biochemistry and Behavior.

[183]  S. Shioda,et al.  Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus , 2002, Neuroscience Letters.

[184]  B. Levin,et al.  Dysregulation of hypothalamic serotonin turnover in diet-induced obese rats , 2002, Brain Research.

[185]  D. Smith,et al.  Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus , 2002, Brain Research.

[186]  M. Friedman.  Leptin and the Neural Circuit Regulating body Weight and Metabolism , 2002 .

[187]  G. Kennett,et al.  5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253 , 2002, Psychopharmacology.

[188]  G. Frost,et al.  Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[189]  M. Low,et al.  The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis , 2001, International Journal of Obesity.

[190]  Berend Olivier,et al.  Male and female 5-HT1B receptor knockout mice have higher body weights than wildtypes , 2001, Physiology & Behavior.

[191]  P. J. Larsen,et al.  Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. , 2001, Diabetes.

[192]  K. Hosoda,et al.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[193]  D. Murphy,et al.  Maintenance of Serotonin in the Intestinal Mucosa and Ganglia of Mice that Lack the High-Affinity Serotonin Transporter: Abnormal Intestinal Motility and the Expression of Cation Transporters , 2001, The Journal of Neuroscience.

[194]  G. Kennett,et al.  Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors , 2001, Neuropharmacology.

[195]  A. Sleight,et al.  A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze , 2001, Neuropharmacology.

[196]  B. K. Hartman,et al.  Ondansetron attenuates CCK induced satiety and c-fos labeling in the dorsal medulla , 2001, Peptides.

[197]  B. Horwitz,et al.  Meal-induced changes in extracellular 5-HT in medial hypothalamus of lean (Fa/Fa) and obese (fa/fa) Zucker rats , 2001, Brain Research.

[198]  P. J. Larsen,et al.  Leptin Receptor Immunoreactivity Is Present in Ascending Serotonergic and Catecholaminergic Neurons of the Rat , 2001, Neuroendocrinology.

[199]  P. Olszewski,et al.  Paraventricular hypothalamic α-melanocyte-stimulating hormone and MTII reduce feeding without causing aversive effects , 2001, Peptides.

[200]  R. Steiner,et al.  Serotonergic neurons are targets for leptin in the monkey. , 2001, The Journal of clinical endocrinology and metabolism.

[201]  H. Schiöth,et al.  Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat , 2000, Brain Research.

[202]  J. Blundell,et al.  Dose–response effects of orexin-A on food intake and the behavioural satiety sequence in rats , 2000, Regulatory Peptides.

[203]  H. Fink,et al.  Does increased endogenous CCK interact with serotonin to reduce food intake in rats? , 2000, Peptides.

[204]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[205]  Y. Sugimoto,et al.  Serum leptin levels after central and systemic injection of a serotonin precursor, 5-hydroxytryptophan, in mice. , 2000, European journal of pharmacology.

[206]  R. Ahima,et al.  Adipose Tissue as an Endocrine Organ , 2006, Obesity.

[207]  M. Collin,et al.  Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. , 2000, Brain research. Molecular brain research.

[208]  E. sanders-Bush,et al.  Deletion of the Serotonin 5-HT2C Receptor PDZ Recognition Motif Prevents Receptor Phosphorylation and Delays Resensitization of Receptor Responses* , 2000, The Journal of Biological Chemistry.

[209]  C. Rouch,et al.  Activation of hypothalamic insulin by serotonin is the primary event of the insulin–serotonin interaction involved in the control of feeding , 2000, Brain Research.

[210]  S. Fetissov,et al.  Dopamine and serotonin VMN release is related to feeding status in obese and lean Zucker rats , 2000, Neuroreport.

[211]  J. Vry,et al.  Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action , 2000, Neuroscience & Biobehavioral Reviews.

[212]  A. Inui,et al.  Transgenic approach to the study of body weight regulation. , 2000, Pharmacological reviews.

[213]  T. Blackburn,et al.  Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS , 2000, Neuropharmacology.

[214]  A. Rex,et al.  Feeding and 8-OH-DPAT-Related Release of Serotonin in the Rat Lateral Hypothalamus , 2000, Pharmacology Biochemistry and Behavior.

[215]  J. Blundell,et al.  Separate systems for serotonin and leptin in appetite control , 2000, Annals of medicine.

[216]  E. Raff,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[217]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[218]  P. Widdowson,et al.  Increased binding at 5-HT1A, 5-HT1B, and 5-HT2A receptors and 5-HT transporters in diet-induced obese rats , 1999, Brain Research.

[219]  Y. Sugimoto,et al.  The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice. , 1999, European journal of pharmacology.

[220]  M. Dallman,et al.  Rats with Hypothalamic Obesity Are Insensitive to Central Leptin Injections1. , 1999, Endocrinology.

[221]  M. Buemi,et al.  Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. , 1999, The Journal of clinical investigation.

[222]  U. Zippel,et al.  Action of cholecystokinin and serotonin on lateral hypothalamic neurons of rats. , 1999, European journal of pharmacology.

[223]  Clifford B Saper,et al.  Leptin Differentially Regulates NPY and POMC Neurons Projecting to the Lateral Hypothalamic Area , 1999, Neuron.

[224]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[225]  C. Dourish,et al.  5‐HT2C receptor modulation and the treatment of obesity , 1999, Diabetes, obesity & metabolism.

[226]  L. Tecott,et al.  Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice , 1999, Psychopharmacology.

[227]  D. Gietzen,et al.  CCKA and 5-HT3 Receptors Interact in Anorectic Responses to Amino Acid Deficiency , 1999, Pharmacology Biochemistry and Behavior.

[228]  Blundell Je.  The control of appetite: basic concepts and practical implications. , 1999 .

[229]  W. F. Mathes,et al.  The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. , 1999, The Journal of clinical investigation.

[230]  B. Schneeman,et al.  Cholecystokinin and serotonin receptors in the regulation of fat-induced satiety in rats. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[231]  D. Booth,et al.  Macronutrient-specific hungers and satieties and their neural bases, learnt from pre- and post-ingestional effects of eating particular foodstuffs , 1999 .

[232]  J. Blundell.  The control of appetite: basic concepts and practical implications. , 1999, Schweizerische medizinische Wochenschrift.

[233]  H. J. Kim,et al.  Potential strategies for ameliorating early cancer anorexia. , 1999, The Journal of surgical research.

[234]  M. Dallman,et al.  Rats with hypothalamic obesity are insensitive to central leptin injections. , 1999, Endocrinology.

[235]  L. Tecott,et al.  Epilepsy and Obesity in Serotonin 5‐HT2C Receptor Mutant Mice , 1998, Annals of the New York Academy of Sciences.

[236]  R. Emeson,et al.  Identification and Characterization of RNA Editing Events within the 5‐HT2C Receptor a , 1998, Annals of the New York Academy of Sciences.

[237]  A. N. van den Pol,et al.  Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.

[238]  A. Levine,et al.  Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands , 1998, Brain Research.

[239]  S. Leibowitz,et al.  Hypothalamic serotonin in control of eating behavior, meal size, and body weight , 1998, Biological Psychiatry.

[240]  A. Sahu.  Leptin decreases food intake induced by melanin-concentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat. , 1998, Endocrinology.

[241]  S. Nicolaidis,et al.  Determination, Using Microdialysis, of Hypothalamic Serotonin Variations in Response to Different Macronutrients , 1998, Physiology & Behavior.

[242]  J. Halford,et al.  Behavioral Satiety Sequence (BSS) for the Diagnosis of Drug Action on Food Intake , 1998, Pharmacology Biochemistry and Behavior.

[243]  Hanxin Lu,et al.  Intracerebroventricular (i.c.v.) Administration of Mouse Leptin in Rats Behavioral Specificity and Effects on Meal Patterns , 1998, Physiology & Behavior.

[244]  L. Tecott,et al.  Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene , 1998, Nature Medicine.

[245]  S. Nicolaidis,et al.  Combined effect of obesity and aging on feeding-induced monoamine release in the rostromedial hypothalamus of the Zucker rat , 1998, International Journal of Obesity.

[246]  L. Campfield,et al.  Brain administration of OB protein (leptin) inhibits neuropeptide-Y-induced feeding in ob/ob mice , 1998, Regulatory Peptides.

[247]  I. Lucki,et al.  The spectrum of behaviors influenced by serotonin , 1998, Biological Psychiatry.

[248]  D. Coscina,et al.  5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient 1 Published on the world wide web on 10 July 1998. 1 , 1998, Brain Research.

[249]  R. Hen,et al.  Absence of Fenfluramine-Induced Anorexia and Reduced c-fos Induction in the Hypothalamus and Central Amygdaloid Complex of Serotonin 1B Receptor Knock-Out Mice , 1998, The Journal of Neuroscience.

[250]  V. Routh,et al.  Adiposity and serum leptin increase in fatty (fa/fa) BNZ neonates without decreased VMH serotonergic activity. , 1998, The American journal of physiology.

[251]  H. Grill,et al.  Serotonin receptors in the caudal brainstem are necessary and sufficient for the anorectic effect of peripherally administered mCPP , 1998, Psychopharmacology.

[252]  S. Fluharty,et al.  Infusion of the serotonin1B (5-HT1B) agonist CP-93,129 into the parabrachial nucleus potently and selectively reduces food intake in rats , 1998, Psychopharmacology.

[253]  C. Plata-salamán,et al.  Disordered food intake and obesity in rats lacking cholecystokinin A receptors. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[254]  R. Sohr,et al.  CCK-8S Facilitates 5-HT Release in the Rat Hypothalamus , 1998, Pharmacology Biochemistry and Behavior.

[255]  K. Simansky.  Serotonin and the Structure of Satiation , 1998 .

[256]  D. A. Vanderweele.  Insulin as a Satiating Signal , 1998 .

[257]  Z. Zadák,et al.  Ventromedial nucleus of hypothalamus is related to the development of cancer-induced anorexia: in vivo microdialysis study. , 1998, Acta medica.

[258]  Steven R Smith,et al.  A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. , 1998, Endocrinology.

[259]  J. Friedman.  Leptin, leptin receptors and the control of body weight. , 2009, European journal of medical research.

[260]  J. Arch,et al.  Inhibition of Food Response to Intracerebroventricular Injection of Leptin Is Attenuated in Rats With Diet-Induced Obesity , 1997, Diabetes.

[261]  C. Rampon,et al.  Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods , 1997, Neuroscience.

[262]  F. Artigas,et al.  The effect of the selective 5‐HT1A agonists alnespirone (S‐20499) and 8‐OH‐DPAT on extracellular 5‐hydroxytryptamine in different regions of rat brain , 1997, British journal of pharmacology.

[263]  S. Cooper,et al.  Devazepide Attenuates dl-Fenfluramine-Induced Suppression of Gastric Emptying but Not Food Intake in the 17 h Food-Deprived Rat , 1997, Physiology & Behavior.

[264]  R. M. Gentry,et al.  Comparison of Fos induced in rat brain by GLP-1 and amylin , 1997, Regulatory Peptides.

[265]  H. Jackson,et al.  Investigation of the mechanisms underlying the hypophagic effects of the 5‐HT and noradrenaline reuptake inhibitor, sibutramine, in the rat , 1997, British journal of pharmacology.

[266]  Michelle D. Lee,et al.  CP-94,253: a selective serotonin1B (5-HT1B) agonist that promotes satiety , 1997, Psychopharmacology.

[267]  T. Murakami,et al.  Leptin Receptor of Zucker Fatty Rat Performs Reduced Signal Transduction , 1997, Diabetes.

[268]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[269]  H. Kinney,et al.  Anatomic Relationships of the Human Arcuate Nucleus of the Medulla: A Dil‐Labeling Study , 1997, Journal of neuropathology and experimental neurology.

[270]  H. Grill,et al.  d-Fenf luramine Anorexia: Dissociation of Ingestion Rate, Meal Duration, and Meal Size Effects , 1997, Pharmacology Biochemistry and Behavior.

[271]  H. Grill,et al.  Contribution of caudal brainstem to d-fenfluramine anorexia , 1997, Psychopharmacology.

[272]  Roy J Martin,et al.  Evidence for a Central Mechanism of Obesity in the Zucker Rat: Role of Neuropeptide Y and Leptin 1 , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[273]  W. Weiger.  SEROTONERGIC MODULATION OF BEHAVIOUR: A PHYLOGENETIC OVERVIEW , 1997, Biological reviews of the Cambridge Philosophical Society.

[274]  J. Halford,et al.  The 5-HT2 Receptor Agonist MK-212 Reduces Food Intake and Increases Resting but Prevents the Behavioural Satiety Sequence , 1997, Pharmacology Biochemistry and Behavior.

[275]  E. Gibson,et al.  Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. , 1997, Trends in pharmacological sciences.

[276]  M. Hamon,et al.  Ultrastructural localization of 5‐hydroxytryptamine1A receptors in the rat brain , 1996, Journal of neuroscience research.

[277]  S. Woods,et al.  Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[278]  P. J. Larsen,et al.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. , 1996, The American journal of physiology.

[279]  B. Jeanrenaud,et al.  The Weight-Reducing Effect of an Intracerebroventricular Bolus Injection of Leptin in Genetically Obese fa/fa Rats: Reduced Sensitivity Compared With Lean Animals , 1996, Diabetes.

[280]  J. Halford,et al.  The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence , 1996, Physiology & Behavior.

[281]  L. Tartaglia,et al.  Phenotype of fatty Due to Gln269Pro Mutation in the Leptin Receptor (Lepr) , 1996, Diabetes.

[282]  S. Cooper,et al.  Cholecystokinin Modulation of Serotonergic Control of Feeding Behavior , 1996, Annals of the New York Academy of Sciences.

[283]  S. Dryden,et al.  The serotonergic agent fluoxetine reduces neuropeptide y levels and neuropeptide y secretion in the hypothalamus of lean and obese rats , 1996, Neuroscience.

[284]  M. Phillips,et al.  Leptin receptor missense mutation in the fatty Zucker rat , 1996, Nature Genetics.

[285]  K. Simansky,et al.  Serotonergic control of the organization of feeding and satiety , 1995, Behavioural Brain Research.

[286]  B. Guy-grand.  Clinical studies with dexfenfluramine: from past to future. , 1995, Obesity Research.

[287]  Janet,et al.  Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. , 1995, The Journal of clinical investigation.

[288]  L. Buéno,et al.  c-fos expression in specific rat brain nuclei after intestinal anaphylaxis: involvement of 5-HT3 receptors and vagal afferent fibers , 1995, Brain Research.

[289]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[290]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[291]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[292]  S. Nicolaidis,et al.  Spontaneous feeding-related monoamine changes in rostromedial hypothalamus of the obese Zucker rat: A microdialysis study , 1995, Physiology & Behavior.

[293]  M. Raiteri,et al.  In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. , 1995, The Journal of pharmacology and experimental therapeutics.

[294]  P. Södersten,et al.  Inhibition of serotonin synthesis attenuates inhibition of ingestive behavior by CCK-8 , 1995, Pharmacology Biochemistry and Behavior.

[295]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[296]  A. Funakoshi,et al.  An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. , 1995, Biochemical and biophysical research communications.

[297]  R. Samanin,et al.  The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y. , 1995, European journal of pharmacology.

[298]  V. Baudrie,et al.  Cortical [3H]ketanserin binding and 5-HT2A receptor-mediated behavioral responses in obese Zucker rats , 1995, Pharmacology Biochemistry and Behavior.

[299]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[300]  Jacqueline N. Crawley,et al.  Biological actions of cholecystokinin , 1994, Peptides.

[301]  E. Gibson,et al.  d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release. , 1994, European journal of pharmacology.

[302]  I. Ebenezer,et al.  Pretreatment with the 5-HT1A receptor agonists 8-OH-DPAT or gepirone does not attenuate the inhibitory effect of systemically administered cholecystokinin (CCK) on food intake in rats. , 1994, Methods and findings in experimental and clinical pharmacology.

[303]  R Hen,et al.  Enhanced aggressive behavior in mice lacking 5-HT1B receptor. , 1994, Science.

[304]  S. Cooper,et al.  Ondansetron, a selective 5-HT3 receptor antagonist, reduces palatable food consumption in the nondeprived rat , 1994, Neuropharmacology.

[305]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[306]  A. Myerson,et al.  Human Autonomic Pharmacology XVI. Benzedrine Sulfate as an Aid in the Treatment of Obesity , 1994 .

[307]  K. Simansky,et al.  Serotonin contracts the isolated rat pylorus via a 5-HT2-like receptor. , 1994, The American journal of physiology.

[308]  P. Fletcher,et al.  Radiofrequency lesions of the PVN fail to modify the effects of serotonergic drugs on food intake , 1993, Brain Research.

[309]  E. Gibson,et al.  d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors. , 1993, European journal of pharmacology.

[310]  Currie Pj,et al.  Diurnal variations in the feeding response to 8-OH-DPAT injected into the dorsal or median raphe. , 1993 .

[311]  S. Cooper,et al.  The selective 5-HT3 receptor antagonist, ondansetron, augments the anorectic effect of d-amphetamine in nondeprived rats , 1993, Pharmacology, Biochemistry and Behavior.

[312]  S. Caccia,et al.  Reciprocal interaction of 5‐hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats , 1993, British journal of pharmacology.

[313]  F. Artigas,et al.  In Vivo Brain Dialysis Study of the Somatodendritic Release of Serotonin in the Raphe Nuclei of the Rat: Effects of 8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin , 1993, Journal of neurochemistry.

[314]  G. P. Smith,et al.  Cholecystokinin-induced satiety depends on activation of 5-HT1C receptors. , 1993, The American journal of physiology.

[315]  D. Coscina,et al.  Diurnal variations in the feeding response to 8-OH-DPAT injected into the dorsal or median raphe. , 1993, Neuroreport.

[316]  A. Hill,et al.  Dexfenfluramine and appetite in humans. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[317]  K. Simansky,et al.  Peripheral serotonin is an incomplete signal for eliciting satiety in sham-feeding rats , 1992, Pharmacology Biochemistry and Behavior.

[318]  I. Ebenezer.  Effects of the 5-HT1A agonist 8-OH-DPAT on food intake in food-deprived rats. , 1992, Neuroreport.

[319]  K. Simansky,et al.  The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats , 1992, Pharmacology Biochemistry and Behavior.

[320]  S. Nicolaidis,et al.  Spontaneous feeding-related monoaminergic changes in the rostromedial hypothalamus revealed by microdialysis , 1992, Physiology & Behavior.

[321]  G. P. Smith,et al.  The 5-HT1A agonist 8-OH-DPAT attenuates the satiating action of cholecystokinin , 1992, Pharmacology Biochemistry and Behavior.

[322]  M. Hamon,et al.  Quantitative autoradiographic mapping of 5‐HT3 receptors in the rat CNS using [125I]iodo‐zacopride and [3H]zacopride as radioligands , 1992, Synapse.

[323]  R. Samanin,et al.  Role of 5-HT receptors in the effect of d-fenfluramine on feeding patterns in the rat. , 1992, European journal of pharmacology.

[324]  M. Pompeiano,et al.  Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[325]  R. Hen,et al.  Of mice and flies: commonalities among 5-HT receptors. , 1992, Trends in pharmacological sciences.

[326]  R. Stevens,et al.  Peripherally administered 5-hydroxytryptamine elicits the full behavioural sequence of satiety , 1991, Physiology & Behavior.

[327]  G. Woodruff,et al.  Pharmacology of a cholecystokinin receptor on 5‐hydroxytryptamine neurones in the dorsal raphe of the rat brain , 1991, British journal of pharmacology.

[328]  S. Joseph,et al.  Arcuate nucleus projections to brainstem regions which modulate nociception , 1991, Journal of Chemical Neuroanatomy.

[329]  S. Hjorth,et al.  Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. , 1991, Life sciences.

[330]  S. Cooper,et al.  Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding , 1990, Physiology & Behavior.

[331]  K. Simansky,et al.  Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: Comparison with directly acting 5-HT agonists , 1990, Brain Research Bulletin.

[332]  J. Lauder.  Ontogeny of the Serotonergic System in the Rat: Serotonin as a Developmental Signal a , 1990, Annals of the New York Academy of Sciences.

[333]  P. Fletcher,et al.  Dorsal raphe microinjection of 5-HT and indirect 5-HT agonists induces feeding in rats. , 1990, European journal of pharmacology.

[334]  R. Huupponen,et al.  Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats. , 1990, Neuroendocrinology.

[335]  G. P. Smith,et al.  Endogenous cholecystokinin reduces feeding in young rats. , 1990, Science.

[336]  S. Cooper,et al.  Reversal of the anorectic effect of (+)‐fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK‐329 , 1990, British journal of pharmacology.

[337]  E. Tiligada,et al.  Regulation of α-melanocyte-stimulating hormone release from superfused slices of rat hypothalamus by serotonin and the interaction of serotonin with the dopaminergic system inhibiting peptide release , 1989, Brain Research.

[338]  N. Bowery,et al.  The 5-HT3 receptor ligand, [3H]BRL 43694, binds to presynaptic sites in the nucleus tractus solitarius of the rat , 1989, Neuropharmacology.

[339]  J. Gibbs,et al.  Cholecystokinin-induced anorexia depends on serotoninergic function. , 1989, The American journal of physiology.

[340]  B. Hoebel,et al.  Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis , 1989, Brain Research.

[341]  B. Hoebel,et al.  Feeding increases extracellular serotonin in the lateral hypothalamus of the rat as measured by microdialysis , 1989, Brain Research.

[342]  K. Simansky,et al.  Peripherally administered α-methyl‐5-hydroxy‐tryptamine and 5‐carboxamidotryptamine reduce food intake via different mechanisms in rats , 1989, Behavioural pharmacology.

[343]  A. Kerlavage,et al.  Evolution of neurotransmitter receptor systems , 1988, Progress in Neurobiology.

[344]  H. Imura,et al.  Monoamine metabolism and its responses to food deprivation in the brain of Zucker rats , 1988, Physiology & Behavior.

[345]  C. Dourish,et al.  Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. , 1988, European journal of pharmacology.

[346]  D. Murphy,et al.  Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. , 1988, European journal of pharmacology.

[347]  C. Bendotti,et al.  The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats. , 1987, Life sciences.

[348]  S. Garattini,et al.  Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system , 1986, Appetite.

[349]  J. Trouvin,et al.  Ontogeny of brain monoamines in lean and obese female Zucker rats , 1986, Physiology & Behavior.

[350]  J. Blundell.  Serotonin manipulations and the structure of feeding behaviour , 1986, Appetite.

[351]  C. Dourish,et al.  Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. , 1986, European journal of pharmacology.

[352]  J. Palacios,et al.  Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites , 1986, Brain Research.

[353]  C. Bendotti,et al.  8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons. , 1986, European journal of pharmacology.

[354]  C. Dourish,et al.  Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) , 1985, Brain Research Bulletin.

[355]  J. Crawley,et al.  Paraventricular nucleus lesions abolish the inhibition of feeding induced by systemic cholecystokinin , 1985, Peptides.

[356]  M. Palkovits,et al.  Analysis of the ACTH/β-End/α-MSH-Immunoreactive afferent input to the hypothalamic paraventricular nucleus of rat , 1984, Brain Research.

[357]  Clifford B. Saper,et al.  Subnuclear organization of the efferent connections of the parabrachial nucleus in the rat , 1984, Brain Research Reviews.

[358]  P S Kalra,et al.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. , 1984, Endocrinology.

[359]  P. Fletcher,et al.  Effects of manipulations of peripheral serotonin on feeding and drinking in the rat , 1984, Pharmacology Biochemistry and Behavior.

[360]  C. Jacquot,et al.  Fenfluramine and brain transmitters in the obese zucker rat , 1984, Neuropharmacology.

[361]  M. Palkovits,et al.  Analysis of the ACTH/beta-End/alpha-MSH-immunoreactive afferent input to the hypothalamic paraventricular nucleus of rat. , 1984, Brain research.

[362]  B. Levin,et al.  Altered sympathetic activity during development of diet-induced obesity in rat. , 1983, The American journal of physiology.

[363]  S. Woods,et al.  The role of insulin as a satiety factor in the central nervous system. , 1983, Advances in metabolic disorders.

[364]  J. Fischer,et al.  Brain serotonergic activity and plasma amino acid levels in genetically obese Zucker rats , 1982, Pharmacology Biochemistry and Behavior.

[365]  J. Pollock,et al.  Peripherally administered serotonin decreases food intake in rats , 1981, Pharmacology Biochemistry and Behavior.

[366]  R. Samanin,et al.  Effects of anorectic drugs and prior feeding on food-rewarded runway behavior , 1981, Pharmacology Biochemistry and Behavior.

[367]  R. Wurtman,et al.  Precursor control of neurotransmitter synthesis. , 1980, Pharmacological reviews.

[368]  A. Drewnowski,et al.  Effects of d-amphetamine and fenfluramine on feeding patterns and activity of obese and lean Zucker rats , 1980, Pharmacology Biochemistry and Behavior.

[369]  S. Woods,et al.  Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons , 1979, Nature.

[370]  B. Hoebel,et al.  Hyperphagia following intraventricular p-chlorophenylalanine-, leucine- or tryptophan-methyl esters: Lack of correlation with whole brain serotonin levels , 1979, Pharmacology Biochemistry and Behavior.

[371]  J. Blundell,et al.  Evidence for the effect of tryptophan on the pattern of food consumption in free feeding and food deprived rats. , 1979, Life sciences.

[372]  M. Wayner,et al.  Effects of various periods of food deprivation on serotonin synthesis in the lateral hypothalamus , 1978, Pharmacology Biochemistry and Behavior.

[373]  B. Clineschmidt,et al.  A 5‐HYDROXYTRYPTAMINE‐LIKE MODE OF ANORECTIC ACTION FOR 6‐CHLORO‐2‐[1‐PIPERAZINYL]‐PYRAZINE (MK‐212) , 1978, British journal of pharmacology.

[374]  J. Blundell.  Is there a role for serotonin (5-hydroxytryptamine) in feeding? , 1977, International journal of obesity.

[375]  B. Jacobs,et al.  An animal behavior model for studying central serotonergic synapses. , 1976, Life sciences.

[376]  D. Segal,et al.  Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways , 1976, Brain Research.

[377]  A. Goudie,et al.  Effects of Lilly 110140, a specific inhibitor of 5‐hydroxytryptamine uptake, on food intake and on 5‐hydroxytryptophan‐induced anorexia. Evidence for serotoninergic inhibition of feeding , 1976, The Journal of pharmacy and pharmacology.

[378]  A M Barrett,et al.  Inhibition of drug‐induced anorexia in rats by methysergide , 1975, The Journal of pharmacy and pharmacology.

[379]  G. P. Smith,et al.  Cholecystokinin elicits the complete behavioral sequence of satiety in rats. , 1975, Journal of comparative and physiological psychology.

[380]  J. Blundell,et al.  The effect of 5‐hydroxytryptophan on food intake and on the anorexic action of amphetamine and fenfluramine , 1975, The Journal of pharmacy and pharmacology.

[381]  B. Clineschmidt,et al.  Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloromethamphetamine. , 1974, European journal of pharmacology.

[382]  G. P. Smith,et al.  Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.

[383]  J. Blundell,et al.  Biphasic action of a 5‐hydroxytryptamine inhibitor on fenfluramine‐induced anorexia , 1973, The Journal of pharmacy and pharmacology.

[384]  J. Scheel-Krüger,et al.  Evidence for a difference in mechanism of action between fenfluramine‐ and amphetamine‐induced anorexia , 1973, The Journal of pharmacy and pharmacology.

[385]  L. Valzelli,et al.  The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine. , 1972, European journal of pharmacology.

[386]  M. H. Joseph,et al.  EFFECTS OF IMMOBILIZATION AND FOOD DEPRIVATION ON RAT BRAIN TRYPTOPHAN METABOLISM , 1972, Journal of neurochemistry.

[387]  R. Wurtman,et al.  Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet , 1971, Science.

[388]  S. Bergen.  APPETITE STIMULATING PROPERTIES OF CYPROHEPTADINE. , 1964, American journal of diseases of children.

[389]  C. A. Stone,et al.  ANTISEROTONIN-ANTIHISTAMINIC PROPERTIES OF CYPROHEPTADINE , 1961 .

[390]  G. C. Kennedy,et al.  The role of depot fat in the hypothalamic control of food intake in the rat , 1953, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[391]  M. Nathanson.  THE CENTRAL ACTION OF BETAAMINOPROPYLBENZENE (BENZEDRINE): CLINICAL OBSERVATIONS , 1937 .

[392]  M. Prinzmetal,et al.  THE USE OF BENZEDRINE FOR THE TREATMENT OF NARCOLEPSY , 1935 .